Motion Sickness Relief Tablet, Chewable
Product Images NDC 69842-395

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Motion Sickness Relief (NDC 69842-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Pharmacy, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cvsb36-00 (Cvsb36 00)

This drug facts panel for Motion Sickness Relief (Meclizine HCl) chewable tablets provides safety warnings, directions for use, phenylketonurics information, storage instructions, inactive ingredients, and a contact phone number for questions or comments. It advises consulting a doctor before use if pregnant or breast-feeding and to keep out of reach of children.*

FDA Label Image

Cvsf36-00 (Cvsf36 00)

Drug Facts panel for Motion Sickness Relief chewable tablets containing 25 mg Meclizine HCl. Covers active ingredient, use for nausea, vomiting, dizziness prevention, warnings against use in children under 12 without doctor advice, and conditions requiring doctor consultation before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.